MedTrace Logo

Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation

NCT02691104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-09-27

No results posted yet for this study

Summary

The investigators are carrying out a feasibility study to explore whether an app for physical activity in Chronic Obstructive Pulmonary Disease (COPD) is acceptable to people with the condition and to healthcare professionals who help patients manage the condition.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DEVICE

SMART COPD app to promote physical activity in COPD. Used in conjunction with a Fitbit Charge

An app which allows users to set physical activity goals, monitors progress towards those goals, and provides feedback to users. Several options for types of physical activity (daily walk, daily step count, and aerobic / strengthening exercises) which can be tailored to the individual user. Designed to be used in consultation with a physiotherapist initially, and then used independently by the individual with COPD. The app will first be used alongside pulmonary rehabilitation (PR), with physiotherapist advice on exercises and setting goals. After PR the individual with COPD will receive weekly contact from a physiotherapist for the first 4 weeks, and then no contact for the second 4 weeks

DEVICE

Control

Participants will follow the (usual care) PR programme. They will be asked to wear a blinided (cannot see step count) Fitbit Charge during the time they are on PR and then for 8 weeks afterwards

Sponsors & Collaborators

  • University of Sheffield

    collaborator OTHER

  • National Institute for Health Research: CLAHRC YH

    collaborator UNKNOWN

  • The Rotherham NHS Foundation Trust

    collaborator UNKNOWN

  • Doncaster And Bassetlaw Hospitals NHS Foundation Trust

    collaborator OTHER

  • Sheffield Teaching Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Mark Hawley · University of Sheffield

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02691104 on ClinicalTrials.gov